GlobalIPNews

Sign Up
|
Login
|

12:23:51 Sat 13 Jun 2026

Home
About Us
Industry
Assignee
Country
Support
Products
Services
View ALl

News For Last 1 Week

Industry

X

Assignee

X

Shanghai Jiao Tong Univer

(28)

Tianjin University

(18)

Hoffmann La Roche

(15)

Regeneron Pharmaceuticals

(11)

Gilead Sciences

(10)

(8)

Jiangsu Hengrui Pharmaceu

(7)

(6)

(5)

Beijing Sun Novo Pharmace

(5)

Chia Tai Tianqing Pharmac

(5)

Daewoong Pharmaceutical

(5)

Eli Lilly and Company

(5)

Hunan Yineng Biological M

(5)

Tianjin University of Sci

(5)

Boehringer Ingelheim Inte

(4)

China Pharmaceutical Univ

(4)

Guangdong Pharmaceutical

(4)

(4)

Jiangsu Hengrui Medicine;

(4)

Jilin University

(4)

(4)

Sartorius Stedim Biotech

(4)

Shanghai Hansoh Biomedica

(4)

Tianjin University of Tra

(4)

Acadia Pharmaceuticals

(3)

(3)

Amylyx Pharmaceuticals

(3)

Astellas Pharma

(3)

(3)

Dongfeng Motor Group; Sha

(3)

Flagship Pioneering Innov

(3)

Genzyme Corporation

(3)

Glaxosmithkline Biologica

(3)

Guangdong Lanyu Biotechno

(3)

Guangxi University of Chi

(3)

Huazhong Pharmaceutical C

(3)

Hubei Gedian Humanwell Ph

(3)

Innovent Biologics, Suzho

(3)

Janssen Pharmaceutica

(3)

Jiangsu Dongkang Biomedic

(3)

Jiangsu Hengrui Pharmaceu

(3)

Jiaxing Baimei Jihua Phar

(3)

(3)

Lunan Pharmaceutical Grou

(3)

(3)

Nanjing Well Pharmaceutic

(3)

Persio Pharmaceuticals In

(3)

Qilu Pharmaceutical

(3)

Revolution Medicines

(3)

(3)

Shanghai Argo Biopharmace

(3)

Shanghai Jemincare Pharma

(3)

Shenyang Pharmaceutical U

(3)

Shenzhen Salubris Pharmac

(3)

Sichuan Neo Green Pharmac

(3)

Syndax Pharmaceuticals In

(3)

Toa Pharmaceuticals Co Lt

(3)

Xizang Haisco Pharmaceuti

(3)

Yichang Humanwell Pharmac

(3)

Zhejiang University

(3)

Affiliated Hospital of Na

(2)

Alnylam Pharmaceuticals

(2)

Ariel Scientific Innovati

(2)

Arvinas Operations

(2)

Ascletis Pharma China Co

(2)

Atossa Therapeutics

(2)

Bashanhong Beijing Pharma

(2)

Beijing Tide Pharmaceutic

(2)

Beijing Yuanda Xinghuo Ph

(2)

Bluerock Therapeutics Lp

(2)

Boehringer Ingelheim Vetm

(2)

Capital University of Med

(2)

Cedilla Therapeutics

(2)

Changsha Stem Cell And Re

(2)

Changzhou University

(2)

China Resources Finance N

(2)

Chupu Chuangzhi Wuhan Pha

(2)

Click Therapeutics

(2)

(2)

Dalian Medical University

(2)

Delphia Therapeutics Inc

(2)

Disarm Therapeutics

(2)

(2)

Dyno Therapeutics

(2)

(2)

(2)

Forcast Orthopedics Inc

(2)

(2)

Fuzhou Maixin Biotechnolo

(2)

Fuzhou Neptunus Fuyao Pha

(2)

Gansu Hengbo Tech Co Ltd

(2)

Genentech; Hoffmann La Ro

(2)

Guangdong University of T

(2)

Haisco Pharmaceutical Gro

(2)

Hangzhou Fst Pharmaceutic

(2)

Hangzhou Grand Biological

(2)

Hangzhou Hospital of Trad

(2)

Harbin Institute of Techn

(2)

Hebei University of Techn

(2)

Heilongjiang University o

(2)

Henan Univ Of Medicine

(2)

Hoffmann-La Roche

(2)

Hubei Changjiang Ruiyi Ph

(2)

Hubei Gedian Humanwell Ph

(2)

Ignis Therapeutics Suzhou

(2)

Ilko Ilac Sanayi Ve Ticar

(2)

Insilico Medicine

(2)

Intas Pharmaceuticals

(2)

Intervet Int B V [nl]; In

(2)

Ionis Pharmaceuticals

(2)

(2)

Jiangnan University

(2)

Jiangsu Carephar Pharmace

(2)

Jiangsu Food & Pharmaceut

(2)

Jiangsu Hengrui Pharmaceu

(2)

Jiangsu Hi Stone Pharmace

(2)

Jiangsu Nhwa Pharmaceutic

(2)

Jiangsu Zhongbang Pharmac

(2)

Jiming Pharmatech Suzhou

(2)

(2)

Kunming Institute of Bota

(2)

Lantern Pharma Inc

(2)

Leti Pharma S L U

(2)

Morphic Therapeutic

(2)

Nanjing Medical Universit

(2)

Nanjing University of Chi

(2)

(2)

(2)

PLA Air Force Medical Uni

(2)

Peking University First H

(2)

Persio Pharmaceuticals In

(2)

(2)

(2)

Regents of the University

(2)

Renji Hospital Shanghai J

(2)

Ruijin Hospital Shanghai

(2)

Ryvu Therapeutics

(2)

Shaanxi University of Chi

(2)

Shandong Huachen Pharmace

(2)

Shandong Linuo Pharmaceut

(2)

Shandong University

(2)

Shandong Xinhua Pharmaceu

(2)

Shanghai 9th People\'s Ho

(2)

Shanghai Aobo Bio Pharmac

(2)

Shanghai Huao Co Ltd

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Tongjin Stem Cel

(2)

Shanxi Pude Pharmaceutica

(2)

Shenzhen Lianxu Pharmaceu

(2)

Sichuan Dingke Pharmaceut

(2)

Simcere Pharmaceutical Co

(2)

Sinocaber Pharmaceutical

(2)

Steinbeis Transfer Gmbh

(2)

Suzhou Oulit Biopharmaceu

(2)

Taiho Pharmaceutical

(2)

Takeda Pharmaceuticals

(2)

Teh Seng Pharmaceutical M

(2)

The Broad Inst Inc [us];

(2)

The Second Xiangya Hospit

(2)

Tianjin University; Tianj

(2)

Treeline Biosciences

(2)

University Berlin Charite

(2)

Velavigo Bio Inc [us]; Ve

(2)

West China Hospital, Sich

(2)

Wuhan Guanggu Zhongyuan P

(2)

Wuzheng Intelligent Tech

(2)

(2)

Xinjiang Huachun Biologic

(2)

Ya Therapeutics Inc

(2)

(2)

Zhejiang University of Te

(2)

Zhejiang Yulong Pharmaceu

(2)

1910 Genetics Inc

(1)

3dmed Biomedical Shanghai

(1)

4e Therapeutics

(1)

858 Therapeutics

(1)

9163 0384 Quebec Inc

(1)

A2a Pharmaceuticals Inc

(1)

ADARx Pharmaceuticals

(1)

(1)

(1)

Abbisko Therapeutics

(1)

Ablynx Nv [be]; Sanofi

(1)

Abtis Co Ltd [kr]; Resear

(1)

Accendatech Co Ltd [cn];

(1)

Acerand Therapeutics (Hon

(1)

Achieve Life Sciences Inc

(1)

Aconcagua Bio Inc

(1)

Adcentrx Therapeutics Inc

(1)

Adripharma Gmbh

(1)

(1)

Affiliated Hospital Of Ch

(1)

Affiliated Hospital Of Sh

(1)

Affiliated Hospital Xuzho

(1)

Affimed Gmbh [de]; Bootst

(1)

Agna Biopharmaceuticals I

(1)

Akebia Therapeutics

(1)

Alchemab Therapeutics Ltd

(1)

Alexia Therapeutics

(1)

Alicorn Pharmaceutical Co

(1)

(1)

Allergan Pharmaceuticals

(1)

Altin Biosciences Corp

(1)

(1)

(1)

Amunix Pharmaceuticals

(1)

(1)

Amytrx Therapeutics Inc

(1)

Anadolu Univ Strateji Gel

(1)

Anhui Joyfar Pharmaceutic

(1)

Anhui University of Chine

(1)

Anhui Zhishan Packaging T

(1)

(1)

Anqing Normal University

(1)

Anxo Pharmaceutical

(1)

Anyong Biotechnology Inc

(1)

Aobio Pharmaceutical Co L

(1)

Aozhilin Beijing Biotechn

(1)

Apollo Ap43 Ltd

(1)

Apotheka Active Ingredien

(1)

Applied Pharmaceutical Sc

(1)

Ardis Chemie Gmbh

(1)

Arite Pharmaceutical Co L

(1)

Arizona Board of Regents

(1)

Aronora Inc [us]; Oregon

(1)

Arromax Pharmatech Co Ltd

(1)

Arrowhead Res Corporation

(1)

(1)

Asahi Kasei Pharma Corp

(1)

Ascentage Pharma Suzhou C

(1)

(1)

Aska Pharm Co Ltd [jp]; N

(1)

Assia Chemical Ind Ltd

(1)

AstraZeneca Ireland

(1)

Astrid Pharma Corp

(1)

Astrocyte Pharmaceuticals

(1)

(1)

Atai Therapeutics

(1)

Ategenos Pharmaceuticals

(1)

Athena Pharmaceutiques Sa

(1)

Austar Pharmaceutical Equ

(1)

Autobio Experimental Inst

(1)

Averna Therapeutics Ltd

(1)

Avidity Biosciences Llc

(1)

Axxelent Pharma Science P

(1)

Azurity Pharmaceuticals

(1)

Bainian Therapeutics Inc

(1)

Baisite Pharmaceutical Gu

(1)

Bala Therapeutics

(1)

BeiGene Switzerland

(1)

Beijing Beimei Pharmaceut

(1)

Beijing Cancer Hospital;

(1)

Beijing Chaoyang Hospital

(1)

Beijing Chest Hospital Ca

(1)

Beijing Fuyuan Pharmaceut

(1)

Beijing Gengshi Co Ltd

(1)

Beijing Hengtaikang Pharm

(1)

Beijing Hollycon Medicine

(1)

Beijing Huahao Zhongtian

(1)

Beijing Innocare Pharma T

(1)

Beijing Inst Of Heart Lun

(1)

Beijing Maxinovel Pharmac

(1)

Beijing Puer Weiye Biolog

(1)

Beijing Shanhai Chushi In

(1)

Beijing Sunho Pharmaceuti

(1)

Beijing Union University

(1)

Beijing University of Che

(1)

Beijing University of Chi

(1)

Beijing Xianhan Guoke Bio

(1)

Beijing Zhongguancun Univ

(1)

Bell Polyester Products I

(1)

Bell Therapeutics

(1)

(1)

Beyond Foam Inc

(1)

Bide Pharmatech Co Ltd

(1)

Big Health Res Institute

(1)

Big Health Res Institute

(1)

Binacea Pharma Inc

(1)

Binzhou Medical College

(1)

(1)

(1)

Biocytogen Pharmaceutical

(1)

Biolexis Therapeutics

(1)

Biology Inst Hebei Academ

(1)

Biomedical Res Group Inc

(1)

(1)

Biotech Pharmaceuticals C

(1)

Biper Therapeutics Sas [f

(1)

Blueprint Medicines

(1)

Bo Hui Biotech Co Ltd

(1)

Boce Biomedical Tianjin C

(1)

Bondibio Pty Ltd

(1)

Boomray Pharmaceuticals C

(1)

Bristol Myers Squibb

(1)

Bsense Bio Therapeutics L

(1)

C/o Animal Microbiome Ana

(1)

(1)

Cancer Hospital, CAMS

(1)

Canvest Wuhan Biotechnolo

(1)

Captor Therapeutics

(1)

Cardiol Therapeutics Inc

(1)

Caribou Biosciences

(1)

Carmot Therapeutics

(1)

Carnos Therapeutics Inc

(1)

Catarc Automotive Test Ce

(1)

Catholic Univ Industry Ac

(1)

(1)

(1)

Central South University

(1)

Centro Di Riferimento Onc

(1)

Cg Pharmaceuticals Inc

(1)

Changchun Genescience Pha

(1)

Changchun Institute of Bi

(1)

Changchun Lanjiang Pharma

(1)

Changchun University of C

(1)

Changchun University of T

(1)

Changshan Conjuchem Bioph

(1)

Changzhou Bohiv Pharmaceu

(1)

Changzhou Jiade Pharmaceu

(1)

Changzhou No 4 Pharmaceut

(1)

Changzhou Pharmaceutical

(1)

Chengdu Anlite Pharmaceut

(1)

Chengdu Chipscreen Pharma

(1)

Chengdu Hyperway Pharmace

(1)

Chengdu Jinshan Chemical

(1)

Chengdu Kanghong Pharmace

(1)

Chengdu Medical College

(1)

Chengdu Saien Jinuo Biote

(1)

Chengdu Tailibei Pharmace

(1)

Chengdu University of Tra

(1)

Chiatai Qingchunbao Pharm

(1)

China Academy of Chinese

(1)

China Chemical & Pharmace

(1)

China Nat Offshore Oil Co

(1)

China Railway 18th Bureau

(1)

China Resources Sanjiu Me

(1)

China West Normal Univers

(1)

Chinese Medicine Guangdon

(1)

Chinese University of Hon

(1)

Chong Kun Dang Pharmaceut

(1)

Chongqing Kerui Pharmaceu

(1)

Chongqing Medical Univers

(1)

Chongqing Pharscin Pharma

(1)

Chongqing Traditional Chi

(1)

Chongqing University

(1)

Chongqing Xinongdakexin A

(1)

Chongqing Zhihe Bio Pharm

(1)

Chugai Seiyaku Kk [jp]; G

(1)

Chung Shan Medical Univ H

(1)

(1)

Cinkate Pharmaceutical In

(1)

Clearmind Labs Corp

(1)

Coherent Biopharma, Suzho

(1)

Columbia University

(1)

Comanche Biopharma Inc

(1)

Compass Pathfinder

(1)

Concaro Therapeutics Inc

(1)

Concept To Medicine Biote

(1)

Contex Biosciences Usa In

(1)

(1)

Covidien Pharmaceuticals

(1)

Crick Therapeutics Ltd

(1)

Cspc Baike Shandong Bio P

(1)

Curaem Pharmaceuticals Pt

(1)

Curon Biopharmaceutical S

(1)

D & D Pharma Tech Inc

(1)

(1)

Daan Biotherapeutics Co L

(1)

Dahan Pharmaceutical Hena

(1)

Daiichi Sankyo Healthcare

(1)

Dalian Polytechnic Univer

(1)

Dana Farber Cancer Inst I

(1)

Dana-Farber Cancer Instit

(1)

Dang Mickael [fr]; Shoich

(1)

Debiopharm International

(1)

Deep Apple Therapeutics I

(1)

Denali Therapeutics

(1)

(1)

Design Therapeutics

(1)

Deutsches Krebsforschungs

(1)

Dewpoint Therapeutics Inc

(1)

Dezhou Kinsana Pharmaceut

(1)

Dezhou Lanli Biotechnolog

(1)

Diabetic Foot Care Sp Z O

(1)

Diagnostica Stago

(1)

(1)

Dongfang Hospital Beijing

(1)

Dongguan Lanwei Medical L

(1)

Dongzhimen Hospital Beiji

(1)

Dragonfleye Therapeutics

(1)

Duality Biologics Suzhou

(1)

Dxm Pharmaceutical Inc

(1)

East China Normal Univers

(1)

East China Normal Univers

(1)

East China University of

(1)

Egyt Gyogyszervegyeszeti

(1)

Eikon Therapeutics

(1)

Eindhoven University of T

(1)

Eisbach Bio Gmbh

(1)

Elanco Animal Health

(1)

Electric Power Res Inst S

(1)

Eleos Pharmaceuticals Inc

(1)

(1)

Emergent Biodefense Opera

(1)

Emory Univ [us]; The Rese

(1)

Emory University

(1)

Enalare Therapeutics

(1)

(1)

Epitech Group S P A

(1)

Erasmus Univ Rotterdam Me

(1)

Erchu of China Railway Tu

(1)

Esapharma S P A

(1)

Espervita Therapeutics

(1)

(1)

Eubulus Biotherapeutics H

(1)

Euregen Biopharma

(1)

Evans David [ca]; Noyce R

(1)

Evotec Int Gmbh

(1)

(1)

F Hoffmann La Roche Ag [c

(1)

(1)

Fasikl Incorporated [us];

(1)

Feiman Changchun Pharmace

(1)

First Affiliated Hospital

(1)

First Affiliated Hospital

(1)

Formosa Laboratories Inc

(1)

Fortvita Biologics Inc

(1)

(1)

Fujian Leephick Pharmaceu

(1)

(1)

Fundacion Para La Formaci

(1)

Fusion Pharmaceuticals

(1)

Fuzhou Tianweida Informat

(1)

Fuzhou Zhixin Future Elec

(1)

Gannan Medical University

(1)

Gansu Institute for Drug

(1)

Gansu Pharmaceutical Grou

(1)

(1)

Genentech Inc [us]; F Hof

(1)

Genentech Inc [us]; Ferma

(1)

Genentech Inc [us]; Hoffm

(1)

Genentech Inc [us]; Xenco

(1)

(1)

Genfleet Therapeutics Sha

(1)

Genhouse Pharmaceutical S

(1)

Germfree Laboratories Llc

(1)

Gilgamesh Pharmaceuticals

(1)

(1)

GlaxoSmithKline Biologica

(1)

GlaxoSmithKline Intellect

(1)

Glory Age Co Ltd

(1)

Golden Health Guangdong B

(1)

Governing Council Univ To

(1)

Grassmedi Co Ltd

(1)

Green Cross Corp [kr]; Ha

(1)

Guangdong B&h Health Care

(1)

Guangdong Huanan Pharmacy

(1)

Guangdong Insight Biochem

(1)

Guangdong Kingfa Scientif

(1)

Guangdong Nanguo Pharmace

(1)

Guangdong Yangble Biophar

(1)

Guangdong Yifang Pharmace

(1)

Guangdong Ziying Kangyan

(1)

Guangxi Baiyunshan Yingka

(1)

Guangxi Chuanji Yiyangjin

(1)

Guangxi Inst Chinese Medi

(1)

Guangxi Veterinary Res In

(1)

Guangxi Wuzhou Pharm Grou

(1)

Guangxi Zhuang Autonomous

(1)

Guangzhou Baiji Shenzhou

(1)

Guangzhou Baiyunshan Pang

(1)

Guangzhou Chia Tai Innova

(1)

Guangzhou Chuangrui Healt

(1)

Guangzhou Hanfang Pharmac

(1)

Guangzhou Hanmay Cosmetic

(1)

Guangzhou Jinmanli Pharma

(1)

Guangzhou Magpie Pharmace

(1)

Guangzhou Medical Univers

(1)

Guangzhou Soyoang Biotech

(1)

Guangzhou Unirise Pharmac

(1)

Guangzhou University of C

(1)

Guangzhou Weinuo Animal P

(1)

Guangzhou Yuanxiang Biote

(1)

Guangzhou Yuezhilian Inte

(1)

Guilin Pharmaceutical Co

(1)

Guizhou Jinqianguo Biotec

(1)

Guizhou University of Tra

(1)

Guozhong Kangjian Beijing

(1)

Gwangju Inst Of Science A

(1)

H&a Pharmachem Co Ltd

(1)

Haichang Biotech Co Ltd

(1)

Hainan Asia Pharmaceutica

(1)

Hainan Demeiyi Pharmaceut

(1)

Hainan Meien Kangxin Medi

(1)

Hainan Yaji Invest Co Ltd

(1)

Haisco Pharmaceutical Gro

(1)

Halda Therapeutics OpCo

(1)

(1)

Hangzhou Ganzhicao Tech C

(1)

Hangzhou Guorui Biotechno

(1)

Hangzhou Jianhai Tech Co

(1)

Hangzhou Maidong Shukang

(1)

Hangzhou Medical College

(1)

Hangzhou Nuoao Biomedical

(1)

Hangzhou Shengyu Biomedic

(1)

Hangzhou Shengzhitang Bio

(1)

Hangzhou Xianweida Biotec

(1)

Hangzhou Yilan Biotechnol

(1)

Hangzhou Yizhengyun Biome

(1)

Hangzhou Zhongmei Huadong

(1)

Hanmi Pharmaceutical

(1)

Hansoh Shanghai Healthtec

(1)

Hansom Biotherapeutics Ll

(1)

Harbin Commercial Univers

(1)

Harbin Pharmaceutical Gro

(1)

(1)

Heartseed Inc; Keio Oki

(1)

Hebei Changtian Pharmaceu

(1)

Hebei Huarong Pharmaceuti

(1)

Hebei Jiyuantang Pharmace

(1)

Hebei Kaiwei Hengcheng Ph

(1)

Hebei University of Techn

(1)

Hefei Institutes of Physi

(1)

Hefei Normal University

(1)

Hefei Tiangang Immunology

(1)

Heilongjiang Bayi Agricul

(1)

Heilongjiang Dilong Pharm

(1)

Heilongjiang Jiujiu Pharm

(1)

Heilongjiang Sengong Trad

(1)

Hemostatics Pharmaceutica

(1)

Henan Academy of Medical

(1)

Henan Agricultural Univ [

(1)

Henan Animal Husbandry Te

(1)

Henan Huiguo Pharmaceutic

(1)

Hengjing Hechuang Biologi

(1)

Hepaitech Beijing Biophar

(1)

Hisamitsu Pharmaceutical

(1)

Hoffmann La Roche [ch]; R

(1)

(1)

Huanggang Luban Pharmaceu

(1)

Huanggang Normal Universi

(1)

Huanghe Science & Technol

(1)

Huangshan Tianmu Pharmace

(1)

Huashan Hospital, Fudan U

(1)

Huayi Taikang Pharmaceuti

(1)

Huazhong University of Sc

(1)

Hubei Gongtong Pharmaceut

(1)

Hubei Hongyuan Pharmaceut

(1)

Hubei Lingsheng Pharmaceu

(1)

Hubei Provincial Center f

(1)

Hubei Ruihua Pharmaceutic

(1)

Hubei Waterstone Bio Phar

(1)

Hubei Xili Pharmaceutical

(1)

Hubei Yinuorui Biological

(1)

Huiying Hubei Environment

(1)

Hunan Aikesong Health Man

(1)

Hunan Chunkehui Tradition

(1)

Hunan Dinuo Pharmaceutica

(1)

Hunan Huixin Pharmaceutic

(1)

Hunan Juxiangtang Biologi

(1)

Hunan Lilibao Tech Develo

(1)

Hunan Maige Biomedical Co

(1)

Hunan Meibai Biological P

(1)

Hunan Nonferrous Metals V

(1)

Hunan Province Xiangzhong

(1)

Hunan Runxing Pharmaceuti

(1)

Hunan Shangcheng Biotechn

(1)

Hunan Space Folding Inter

(1)

Hunan Xianshi Pharmaceuti

(1)

Huzhou Zhanwang Pharmaceu

(1)

(1)

IDEAYA Biosciences

(1)

Iambic Therapeutics

(1)

(1)

Impact Therapeutics Shang

(1)

(1)

Ind Chimica S R L

(1)

Initiator Pharma

(1)

Inner Mongolia Huazhou Ph

(1)

Inner Mongolia Research I

(1)

Inner Mongolia University

(1)

Innovec Biotherapeutics

(1)

Innovstone Therapeutics

(1)

Inst Materia Medica Cams

(1)

Institut National De La S

(1)

Institute Military Medici

(1)

Institute Of Artificial I

(1)

Institute Of Basic Res In

(1)

Institute of Chinese Mate

(1)

Insulet Corporation

(1)

Intech Biopharm Ltd

(1)

Integrative Res Laborator

(1)

Intellia Therapeutics

(1)

International Business Ma

(1)

Inventagelab Inc

(1)

(1)

(1)

Ipsen Biopharmaceuticals

(1)

Irbm S P A [it]; C N C C

(1)

Itf Res Pharma Slu

(1)

(1)

Jasper Therapeutics

(1)

Jds Therapeutics Llc

(1)

Jewim Pharmaceutical (Sha

(1)

Jewim Pharmaceutical Rese

(1)

Jhm Biopharmaceutical Han

(1)

Jianghan University

(1)

Jiangnan University; Jian

(1)

Jiangsu Chenxing Pharmace

(1)

Jiangsu Demai Pharmaceuti

(1)

Jiangsu Hansoh Pharmaceut

(1)

Jiangsu Hansyn Pharmaceut

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Jiahao Hot Melt A

(1)

Jiangsu Jiming Pharmaceut

(1)

Jiangsu Jingsen Biologica

(1)

Jiangsu Leeway Biological

(1)

Jiangsu Lianhuan Pharmace

(1)

Jiangsu Pacific Meinuoke

(1)

Jiangsu Province Hospital

(1)

Jiangsu Province Hospital

(1)

Jiangsu Provincial Xuzhou

(1)

Jiangsu Shenhou Pharmaceu

(1)

Jiangsu Tianhe Pharmaceut

(1)

Jiangsu University; Shang

(1)

Jiangsu Wuzhong Pharmaceu

(1)

Jiangsu Zhiyuan Pharmaceu

(1)

Jiangxi Brother Pharmaceu

(1)

Jiangxi Changshuo Outdoor

(1)

Jiangxi Fangzhu Pharmaceu

(1)

Jiangxi Jinding Pharmaceu

(1)

Jiangxi Kerui Pharmaceuti

(1)

Jiangxi Lushan Pharmaceut

(1)

Jiangxi Shimei Pharmaceut

(1)

Jiangxi Sincer Medical Co

(1)

Jiangxian Dev Zone Hongru

(1)

Jiangyin Huacai Shijia Ne

(1)

Jiaozuo Furuitang Pharmac

(1)

Jilin Sihuan Aokang Pharm

(1)

Jilin Univ Of Chemical Te

(1)

Jinan Micro Ecological Bi

(1)

Jinan University

(1)

(1)

Jing Brand; Jinpai Chizhe

(1)

Jingfuda Biotechnology Sh

(1)

Jinghua Pharmaceutical Gr

(1)

Jingsentang Jiangsu Healt

(1)

Jinhua Herui Life Health

(1)

Jining Huaneng Pharmaceut

(1)

Jining Shengtai Pharmaceu

(1)

(1)

Jinyao Darentang Group Co

(1)

Jinyao Heping Tianjin Pha

(1)

Jinzhong Comprehensive In

(1)

Jiuhua Huayuan Pharmaceut

(1)

Jiuzhou Pharmaceutical Ha

(1)

(1)

Junkang Medical Tech Tian

(1)

K36 Therapeutics

(1)

Kaixing Life Tech Shangha

(1)

Kanglin Bio Tech Hangzhou

(1)

Kanglong Huacheng Ningbo

(1)

Kangmei Pharmaceutical

(1)

(1)

Karyopharm Therapeutics

(1)

Kasma Therapeutics Inc

(1)

Keli Italia Co Ltd

(1)

(1)

Kestrel Therapeutics Inc

(1)

Khora Spv 1 Llc

(1)

Kinhoo Pharmaceutical Co

(1)

Kk Yakult Honsha

(1)

Km Biotherapeutics Ag

(1)

Kobayashi Pharmaceutical

(1)

Kuihua Pharmaceutical Gro

(1)

Kymera Therapeutics

(1)

(1)

Laboratoire Francais Du F

(1)

Laekna Pharmaceutical Nin

(1)

Laekna Therapeutics, Shan

(1)

Lanzhou Foci Pharmaceutic

(1)

Laoshan National Laborato

(1)

Lask Pharma Inc

(1)

Lb Pharmaceuticals Inc

(1)

Levena Suzhou Biopharma C

(1)

(1)

(1)

Lianying Yuezhi Scient In

(1)

Liaoning Dekang Pharmaceu

(1)

Liaoning Jiayu Tech Co Lt

(1)

Liaoning Misentang Pharma

(1)

Lilum Therapeutics Inc

(1)

Lingyuan Pharmaceutical C

(1)

Linio Biotech Ltd

(1)

Linyi Kangli Medical Equi

(1)

Lion Corporation

(1)

(1)

Lishizhen Pharmaceutical

(1)

(1)

Liupanshui Animal Health

(1)

Lonza Guangzhou Pharmaceu

(1)

(1)

M Path Biopharma Ltd

(1)

Mablink Bioscience [fr];

(1)

Massachusetts Inst Of Tec

(1)

Max Delbrück Center for

(1)

Maze Therapeutics

(1)

(1)

Medicis Pharmaceutical Co

(1)

Medigen Biotechnology Cor

(1)

(1)

Meiji Holdings Co Ltd

(1)

Meilan Hangzhou Pharmaceu

(1)

Meisida Shanghai Pharmace

(1)

Meiye Biomedical Co Ltd;

(1)

Memorial Sloan Kettering

(1)

Memorial Sloan Kettering

(1)

Merck Sharp & Dohme

(1)

Merck Sharp & Dohme; Sich

(1)

Metimedi Pharmaceuticals

(1)

Microcirculation Inst Chi

(1)

Ming Chi University of Te

(1)

Mirati Therapeutics

(1)

Mitsubishi Gas Chemical

(1)

Momenta Pharmaceuticals

(1)

Monte Rosa Therapeutics

(1)

Mosanna Therapeutics Ag

(1)

Motigenix Singapore Pte L

(1)

NGM Biopharmaceuticals

(1)

Nacuity Pharmaceuticals I

(1)

Nanjing Chia-Tai Tianqing

(1)

Nanjing Daoer Pharmaceuti

(1)

Nanjing Feilikang Pharmac

(1)

Nanjing Hailing Pharmaceu

(1)

Nanjing Jiaxi Kangde Phar

(1)

Nanjing Kangzhou Pharmace

(1)

Nanjing Keluosi Biotechno

(1)

Nanjing Langbote Animal P

(1)

Nanjing Qingpu Biotechnol

(1)

Nanjing Reju Therapeutics

(1)

Nanjing Rentai Beirui Lif

(1)

Nanjing Sanhome Pharmaceu

(1)

Nanjing Suyixin Medicine

(1)

Nanjing Tongnuokang Medic

(1)

Nanjing University of Pos

(1)

Nanjing Weichuangyuan Pha

(1)

Nanjing Zhongkebaier Phar

(1)

Nanjing Zhongshan Pharm C

(1)

Nantong Changyou Pharmace

(1)

Nantong Haifa Intelligent

(1)

Nantong Huaxiang Pharmace

(1)

Nantong University

(1)

Nat Univ Corporation Okay

(1)

National Cheng Kung Unive

(1)

National Health Res Inst

(1)

National Health Research

(1)

National University Corpo

(1)

National Vaccine And Seru

(1)

(1)

Neocannbio Co Ltd [kr]; K

(1)

(1)

(1)

Neuboron Medtech Res Inst

(1)

Neuexcell Therapeutics Su

(1)

Neulix Therapeutics Ab

(1)

Neurimmune Ag [ch]; Alexi

(1)

Neuromusculoskeletal Rege

(1)

NewAmsterdam Pharma

(1)

Nexzol Pharma Inc

(1)

Ningbo Cixi Inst Of Biome

(1)

Ningbo Lianhe Photon Tech

(1)

Ningbo Menovo Tiankang Ph

(1)

Ningbo Yihe Medical Equip

(1)

Ningbo Yuanxin Electronic

(1)

Ningxia Medical Universit

(1)

Ningxia Qiyuan Pharmaceut

(1)

Ningxia Tianxin Pharmaceu

(1)

Ningxia University

(1)

Nkilt Therapeutics Inc

(1)

No 1 Affiliated Hospital

(1)

(1)

(1)

(1)

Noobs Therapeutics Inc

(1)

North China University of

(1)

Northwest Institute Plate

(1)

Northwestern University

(1)

Novartis; Genentech

(1)

Npgs Guangdong Biotechnol

(1)

Nuclear Power Institute o

(1)

Nuclidium Ag [ch]; Univer

(1)

Nutshell Therapeutics Sha

(1)

(1)

Obi Pharma Inc [cn]; Chen

(1)

(1)

Odyssey Therapeutics

(1)

Ono Pharmaceutical Co [jp

(1)

(1)

(1)

Orient Shandong Pharmaceu

(1)

(1)

Orphai Therapeutics Inc

(1)

Oryzon Genomics S A

(1)

Osprey Biopharmaceuticals

(1)

Otsuka America Pharmaceut

(1)

Otsuka Pharma Co Ltd [jp]

(1)

Otsuka Pharmaceutical

(1)

Oxford Univ Innovation Li

(1)

Oyster Point Pharma

(1)

PTC Therapeutics

(1)

Panexo Biotech Sg Pte Ltd

(1)

Panshi Medical Biotechnol

(1)

Passport Tech Inc

(1)

Peking Union Medical Coll

(1)

Peking Union Medical Coll

(1)

Perfect Therapeutics; Reg

(1)

Pharma Foods Int Co Ltd

(1)

Pharmaengine Inc

(1)

Pharmgen Science Inc

(1)

Pharos Ibio Co Ltd

(1)

Pheast Therapeutics Inc

(1)

(1)

Postech Res And Business

(1)

Precise Biopharma Pvt Ltd

(1)

(1)

Principia Biopharma

(1)

Procter & Gamble

(1)

Prospect Therapeutics Nan

(1)

Qihe Frontier Biological

(1)

Qilu Animal Health Produc

(1)

Qilu Hospital of Shandong

(1)

Qilu Pharmaceutical; Shan

(1)

Qilu University of Techno

(1)

Qingdao Baheal Pharmaceut

(1)

Qingdao Biotemed Biomater

(1)

Qingdao Municipal Hospita

(1)

Qingdao Shuojing Biologic

(1)

Qingdao Traditional Chine

(1)

Qinghai Salt Lake Industr

(1)

Qinghai Xiadu Pharmaceuti

(1)

Quantum Science

(1)

Quanzhou Haichuang Pharma

(1)

Qufu Normal University

(1)

(1)

Ractigen Therapeutics

(1)

Ratio Therapeutics Inc

(1)

Rdp Pharma Ag [ch]; Juliu

(1)

Reata Pharmaceuticals Hol

(1)

(1)

Regeneron Pharma [us]; Se

(1)

Relay Therapeutics

(1)

Repurposed Therapeutics I

(1)

Resq Pharmaceuticals Llc

(1)

(1)

Riboscience Llc

(1)

(1)

Roche Diabetes Care Gmbh

(1)

Roquefort Therapeutics Pl

(1)

Royal Melbourne Inst Of T

(1)

Ruenhuei Biopharmaceutica

(1)

Ruijin Hospital Shanghai

(1)

Ruiyin Cell Engineering T

(1)

S Alpha Therapeutics Inc

(1)

ST Superiore Di Sanita [i

(1)

Saiweitai Guangzhou Healt

(1)

Salubris Chengdu Biotech

(1)

Salubritas Therapeutics I

(1)

Samjin Pharmaceutical

(1)

Samjin Pharmaceutical Co

(1)

Sanmenxia Vocational And

(1)

Sanofi Biotechnology [fr]

(1)

Sanofi Sa [fr]; UCB Bioph

(1)

Santhera Pharmaceuticals

(1)

Sanya Central Hospital Ha

(1)

Sanya Yazhouwan Deep Sea

(1)

Sarepta Therapeutics Inc

(1)

Sartorius Stedim FMT

(1)

ScinnoHub Pharmaceutical

(1)

Scribe Therapeutics

(1)

(1)

Seamless Therapeutics Gmb

(1)

Sensorium Therapeutics

(1)

Serina Therapeutics Alaba

(1)

Serum Inst Of India Priva

(1)

Servier Laboratories

(1)

Shaanxi Didu Pharmaceutic

(1)

Shaanxi Dongke Pharmaceut

(1)

Shaanxi Hanjiang Pharmace

(1)

Shaanxi Jianmin Pharmaceu

(1)

Shaanxi Kanghe Li Feng Bi

(1)

Shaanxi Meitian Yigu Agri

(1)

Shaanxi Qinghua Vehicle S

(1)

Shaanxi Rock New Mat Co L

(1)

Shaanxi University of Sci

(1)

Shaanxi Zhongyuan Animal

(1)

Shandong Anhong Pharmaceu

(1)

Shandong Anshun Pharmaceu

(1)

Shandong Boan Biotechnolo

(1)

Shandong Dazhen Pharmacy

(1)

Shandong First Medical Un

(1)

Shandong Haineng Bioengin

(1)

Shandong Lukang Shelile P

(1)

Shandong Luye Pharmaceuti

(1)

Shandong Meizhijian Pharm

(1)

Shandong Nhu Pharmaceutic

(1)

Shandong Province Feed An

(1)

Shandong Ruisheng Pharmac

(1)

Shandong University; Shan

(1)

Shandong Xinyi Pharmaceut

(1)

Shanghai 9th People\'s Ho

(1)

Shanghai Apeiron Therapeu

(1)

Shanghai Bojie Medical Te

(1)

Shanghai Celliver Biotech

(1)

Shanghai Data Group Co Lt

(1)

Shanghai Fosun Pharmaceut

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Hansoh Biomedica

(1)

Shanghai Hongcheng Pharma

(1)

Shanghai Huaota Biopharma

(1)

Shanghai Huayuan Pharmace

(1)

Shanghai Huayuan Pharmacy

(1)

Shanghai Infectious Disea

(1)

Shanghai Innogen Pharmace

(1)

Shanghai Inst Of Infectio

(1)

Shanghai Inst Of Pharmace

(1)

Shanghai Inst Of Pharmace

(1)

Shanghai Institute of Cer

(1)

Shanghai Institute of Mat

(1)

Shanghai Jiading Nanxiang

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jiao Tong Univer

(1)

Shanghai Jide Zhengxing T

(1)

Shanghai Jinfukang Pharma

(1)

Shanghai Jingquan Investm

(1)

Shanghai Jziy Biotechnolo

(1)

Shanghai Maijiao Liuyin B

(1)

Shanghai Maishixi Biomedi

(1)

Shanghai Meiyue Biotech D

(1)

Shanghai Miracogen Inc [c

(1)

Shanghai No 4 People\'s H

(1)

Shanghai Pharmaceutical S

(1)

Shanghai Qilu Pharmaceuti

(1)

Shanghai Qingmei Green Fo

(1)

Shanghai Quietd Biotechno

(1)

Shanghai Regenelead Thera

(1)

Shanghai Senhui Medicine

(1)

Shanghai Shendu Potential

(1)

Shanghai Syncores Tech In

(1)

Shanghai Topscience Co Lt

(1)

Shanghai Univ Of Medicine

(1)

Shanghai University of Tr

(1)

Shanghai Yaxin Biotechnol

(1)

Shanghai Yiding Tech Grou

(1)

Shanghai Yingli Pharmaceu

(1)

Shangqiu Xianghe Pharmace

(1)

Shanneng New Mat Zibo Co

(1)

Shantou Mebo Pharmaceutic

(1)

Shanxi Provincial People\

(1)

Shanxi Xinyu Pharmaceutic

(1)

Shengjing Hospital of Chi

(1)

Shenzhen BGI Life Science

(1)

Shenzhen Bay Laboratory

(1)

Shenzhen Beike BioTechnol

(1)

Shenzhen Haoshi Biologica

(1)

Shenzhen Hepalink Pharmac

(1)

Shenzhen Hightide Biophar

(1)

Shenzhen Huaaisheng Tech

(1)

Shenzhen Hwatime Biologic

(1)

Shenzhen Neptunus Pharmac

(1)

Shenzhen People\'s Hospit

(1)

Shenzhen Ruihua Pharmaceu

(1)

Shenzhen Ruiji Biotechnol

(1)

Shenzhen Salubris Pharm C

(1)

Shenzhen Taili Biological

(1)

Shenzhen University; Zhej

(1)

Shenzhen Wanhe Pharmaceut

(1)

Shenzhen Weiguang Biologi

(1)

Shenzhen YHLO Biotech; Sh

(1)

Shihezi University

(1)

Shijiazhuang Gerui Pharma

(1)

Country

X

China Patent News

Taiwan Patent News

European Patent News

WIPO Patent News

Status

X

1 - 100 of 1619 Items

Sign In / Subscribe

Select All

Share
Download as Excel
Download as PDF

State Intellectual Property Office of China Publishes Shanghai Jiao Tong University and Fudan University Patent Application for Charging Pile Demand Prediction Method Based on Dyna..

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has published Shanghai Jiao Tong University and Fudan University patent application for Charging Pile Demand Prediction Method Based on Dynamic Grouping, Electronic Equipment and Storage Medium. The invention was developed by Chen Yuting, Sun Yaojie, Feng Donghan, H..

State Intellectual Property Office of China Receives Crick Therapeutics Ltd Patent Application for Real-time Provision of Dynamic, Personalized Digital Therapy to User Using Phenot..

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has received Crick Therapeutics Ltd patent application for Real-time Provision of Dynamic, Personalized Digital Therapy to User Using Phenotypic Driven Digital Twinborn Model to Address Obese Conditions. Adler Stefan and Durham Matthew developed the invention. Th..

State Intellectual Property Office of China Publishes Hangzhou Ganzhicao Tech Co Ltd Patent Application for Traditional Chinese Medicine Auxiliary Diagnosis Method and System Combi..

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has published Hangzhou Ganzhicao Tech Co Ltd patent application for Traditional Chinese Medicine Auxiliary Diagnosis Method and System Combining Knowledge Graph and Thinking Chain. The invention was developed by Tu Weihui, Wang Ping, Wang Yanwen and Li Jianmin. T..

Fuzhou Tianweida Information Tech Co Ltd Files Chinese Patent Application for Customized Health Conditioning Scheme Generation System for Traditional Chinese Medicine Four-diagnosi..

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- Fuzhou Tianweida Information Tech Co Ltd has filed a patent application for Customized Health Conditioning Scheme Generation System for Traditional Chinese Medicine Four-diagnosis Instrument. This invention was developed by Chen Mouyu. The patent application number is CN202610134408 20260130. The patent pu..

Yunhai Chain Holdings Co Ltd Submits Patent Application for Traditional Chinese Medicine Decoction Data Processing Method, Device and Equipment and Medium

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- Yunhai Chain Holdings Co Ltd has submitted a patent application for Traditional Chinese Medicine Decoction Data Processing Method, Device and Equipment and Medium. Zhang Yuan, Yan Yun, Lyu Yan, Xu Xiang, Du Daidong and Zhou Qiange developed the invention. The patent application number is CN202511797755 202..

Guozhong Kangjian Beijing Health Man Co Ltd Seeks Patent for Ai-based Method, Device and Equipment for Assisting Diet Conditioning Management and Control of Chronic Diseases of Old..

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- Guozhong Kangjian Beijing Health Man Co Ltd has sought patent for Ai-based Method, Device and Equipment for Assisting Diet Conditioning Management and Control of Chronic Diseases of Old People and Medium. This invention was developed by Wang Meiling, Ma Hongyan, Han Ye-yeon, Chen Jin, Jiao Weiqing, Li Xia, Do..

Bashanhong Beijing Pharmaceutical Tech Co Ltd Seeks Patent for Evaluation Method of PRP (platelet Rich Plasma) Administration Concentration for Joint Movement Injury Repair

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- Bashanhong Beijing Pharmaceutical Tech Co Ltd has sought patent for Evaluation Method of PRP (platelet Rich Plasma) Administration Concentration for Joint Movement Injury Repair. This invention was developed by Liu Xu, Wang Chengzhen and Rao Yiwei. The patent application number is CN202511793956 20251202. ..

Jiangsu Leeway Biological Tech Co Ltd Applies for Patent on Single Drug Administration Data Analysis and Acquisition System

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- Jiangsu Leeway Biological Tech Co Ltd has applied Chinese patent for Single Drug Administration Data Analysis and Acquisition System. Zhou Yaming and Zhang Lei developed it. The patent application number is CN202511806704 20251203. The patent publication number is CN121601123 (A). International Patent Clas..

Wuzheng Intelligent Tech Beijing Co Ltd Submits Patent Application for Method and Device for Generating Traditional Chinese Medicine Five-mark Identification Result Based on Pulse ..

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- Wuzheng Intelligent Tech Beijing Co Ltd has submitted a patent application for Method and Device for Generating Traditional Chinese Medicine Five-mark Identification Result Based on Pulse Condition. Qin Chenhao, Xue Sangni, Zhang Chen and Yang Tingting developed the invention. The patent application number..

Averna Therapeutics Ltd Applies for Patent on Engineered Retrotransposable Element Proteins for Gene Delivery and Insertion

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Averna Therapeutics Ltd has applied Taiwan patent for Engineered Retrotransposable Element Proteins for Gene Delivery and Insertion. Trudeau Devin, Ben Shushan-goleczki Yaron, Gordon Aaron, Kowalsman Noga and Gabay Orshay developed it. The patent application number is TW20240137722 20241003. The patent publ..

Ccbiotech Inc Seeks Patent for Anti-sulfatase-related Antigen Specific Antibody, Detection Kit Comprising Anti-sulfatase-related Antigen Specific Antibody, and Use of Anti-sulfatas..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Ccbiotech Inc has sought patent for Anti-sulfatase-related Antigen Specific Antibody, Detection Kit Comprising Anti-sulfatase-related Antigen Specific Antibody, and Use of Anti-sulfatase-related Antigen Specific Antibody for Detecting and Treating Osteoarthritis. This invention was developed by Jiang Ching-chu..

Taiwan Patent Office Receives Genentech Inc and Xencor Patent Application for Combinations of Il15/il15r Alpha Heterodimeric Fc-fusion Proteins and Her2xcd3 Bispecific Antibodies f..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has received Genentech Inc and Xencor patent application for Combinations of Il15/il15r Alpha Heterodimeric Fc-fusion Proteins and Her2xcd3 Bispecific Antibodies for the Treatment of Her2-positive Cancers. Holder Patrick Gwynn and Junttila Teemu Tapani developed the invention. The paten..

Taiwan Patent Office Publishes Ablynx NV and Sanofi Patent Application for Bi- and Multivalent Albumin Binders

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has published Ablynx NV and Sanofi patent application for Bi- and Multivalent Albumin Binders. The invention was developed by Van Bogaert Tom and Verhelst Judith. The patent application number is TW20240135755 20240920. The patent publication number is TW202532432 (A). International Pat..

Ya Therapeutics Inc Seeks Patent for Preparation and Application of KRAS G12C Mutant Protein Pyrimido-thiapyran Diketone Inhibitor

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Ya Therapeutics Inc has sought patent for Preparation and Application of KRAS G12C Mutant Protein Pyrimido-thiapyran Diketone Inhibitor. This invention was developed by Liang Yong-hong. The patent application number is TW20250103021 20250123. The patent publication number is TW202532417 (A). International P..

Taiwan Patent Office Publishes Sumitomo Pharma Co Ltd and National Cancer Institute Patent Application for Tertiary Amide Derivative Substituted with Four-membered Ring Structure H..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has published Sumitomo Pharma Co Ltd and National Cancer Institute patent application for Tertiary Amide Derivative Substituted with Four-membered Ring Structure Having High Cbp/p300 Inhibition and Featuring Both High Water Solubility for Exerting Anticancer Effects upon Intravenous Admini..

Medigen Biotechnology Corp Submits Patent Application for Use of Muparfostat for Preparing Pharmaceutical Compositions for Treatment of Pancreatic Cancer Can be Used for Reducing F..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Medigen Biotechnology Corp has submitted a patent application for Use of Muparfostat for Preparing Pharmaceutical Compositions for Treatment of Pancreatic Cancer Can be Used for Reducing Fibrosis of Pancreatic Tissue in Pancreatic Cancer Patients. Chang Stanley Shi-zhong, Lin Chieh-liang and Yang Chih-ya devel..

Taiwan Patent Office Releases Santhera Pharmaceuticals Schweiz AG Patent Application for a New Vamorolone Preparation Exhibiting Improved Solubility

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has released Santhera Pharmaceuticals Schweiz AG patent application for a New Vamorolone Preparation Exhibiting Improved Solubility. This invention was developed by Allieri Brigida, Challis Bradley, Chopra Reenu, Diaz Liliana Elizabeth and Hausmann Rudolf. The patent application number ..

Lu Ru Band Files Taiwan Patent Application for Use of Composition for Preparation of Drug for Improving Cognitive Ability Using Dextromethorphan or Valproic Acid to Cure Bipolar Di..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Lu Ru Band has filed a patent application for Use of Composition for Preparation of Drug for Improving Cognitive Ability Using Dextromethorphan or Valproic Acid to Cure Bipolar Disorder. The patent application number is TW20240104719 20240206. The patent publication number is TW202532077 (A). International Pat..

Taiwan Patent Office Receives Genentech Inc, Hoffmann La Roche and Pfizer Patent Application for Combination Therapies for Treatment of Breast Cancer

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has received Genentech Inc, Hoffmann La Roche and Pfizer patent application for Combination Therapies for Treatment of Breast Cancer. Thanopoulou Eirini, Jin Yan-ling, Lei Guiyuan, Neate Colin, Shankar Noopur, Song Chunyan and Stout Thomas James developed the invention. The patent appli..

Lantern Pharma Inc Seeks Patent for Combination of Dimesna and Pemetrexed to Treat Non-small Cell Lung Cancer (NSCLC)

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Lantern Pharma Inc has sought patent for Combination of Dimesna and Pemetrexed to Treat Non-small Cell Lung Cancer (NSCLC). This invention was developed by Bhatia Kishor, Ewesuedo Reggie and Margrave David. The patent application number is TW20240150247 20241223. The patent publication number is TW202532061..

Taiwan Patent Office Releases Jiangsu Hengrui Pharmaceuticals Co Ltd, Suncadia Pharmaceuticals Co Ltd and Chengdu Xinyue Medicine Co Ltd Patent Application for a Crystal of a Nitro..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has released Jiangsu Hengrui Pharmaceuticals Co Ltd, Suncadia Pharmaceuticals Co Ltd and Chengdu Xinyue Medicine Co Ltd patent application for a Crystal of a Nitrogen-containing Bridged Heterocyclic Compound and Preparation Method Thereof. This invention was developed by Zhao Hong, Wan Zhe..

State Intellectual Property Office of China Receives Beijing Chaoyang Hospital of Capital Medical University and Univ Renmin China Patent Application for Lightweight Deep Learning ..

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has received Beijing Chaoyang Hospital of Capital Medical University and Univ Renmin China patent application for Lightweight Deep Learning Model Construction Method and System for Evaluating Chronic Obstructive Pulmonary Disease. Ji Ying, Meng Xiangyu and Zhou Jing..

Hangzhou Grand Biological Pharmaceutical Co Ltd Submits Chinese Patent Application for Double-circuit Power Supply Switching Circuit, Double-circuit Power Supply Switching Method a..

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- Hangzhou Grand Biological Pharmaceutical Co Ltd has submitted a patent application for Double-circuit Power Supply Switching Circuit, Double-circuit Power Supply Switching Method and Switching System. This invention was developed by Fang Ying, Ding Zhelin, Ding Peixi and Wang Hongying. The patent applicati..

State Intellectual Property Office of China Publishes Shanghai Jiao Tong University and Shanghai Zhonglv New Energy Tech Co Ltd Patent Application for Zero Voltage Ride Through Con..

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has published Shanghai Jiao Tong University and Shanghai Zhonglv New Energy Tech Co Ltd patent application for Zero Voltage Ride Through Control Method for Self-synchronizing Voltage Source Doubly-fed Wind Turbine Generator. The invention was developed by Zhang Yu, ..

Taiwan Patent Office Publishes Kestrel Therapeutics Inc Patent Application for RAS Inhibitors and Methods of Use Thereof

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has published Kestrel Therapeutics Inc patent application for RAS Inhibitors and Methods of Use Thereof. The invention was developed by Ahmad Omar K. The patent application number is TW20240137945 20241004. The patent publication number is TW202530225 (A). International Patent Classific..

Delphia Therapeutics Inc Seeks Patent for Compounds, Pharmaceutical Compositions Thereof, and Methods of Using the Same

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Delphia Therapeutics Inc has sought patent for Compounds, Pharmaceutical Compositions Thereof, and Methods of Using the Same. This invention was developed by Usera Aimee, Kirman Louise, Lee Patrick, Burke Michael, Sacher Joshua and Feutrill John Thomas. The patent application number is TW20240138006 2024100..

Pharmaengine Inc Submits Taiwan Patent Application for Mta-cooperative PRMT5 Inhibitor

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Pharmaengine Inc has submitted a patent application for Mta-cooperative PRMT5 Inhibitor. This invention was developed by Liu Cheng-hao, Lin Long-zhi, Wang Hong-ren, Mou Jian-feng, Duan Xin-li, Yu Qing-fang, Chen Ya-yu, Wang Tong, Dong Guang-ping, Chen Bin and Zhang Pei-yu. The patent application number is T..

A2A Pharmaceuticals Inc Submits Patent Application for Methods for Treating Cancers Associated with Transforming Acidic Coiled-coil Proteins

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- A2A Pharmaceuticals Inc has submitted a patent application for Methods for Treating Cancers Associated with Transforming Acidic Coiled-coil Proteins. Lim Chae-min, Vempati Sridhar and Stergiopoulos Sotirios developed the invention. The patent application number is TW20240136676 20240926. The patent publicat..

State Intellectual Property Office of China Receives Hunan Yineng Biological Medicine Co Ltd Patent Application for Quality Control Method and Application of Traditional Chinese Me..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has received Hunan Yineng Biological Medicine Co Ltd patent application for Quality Control Method and Application of Traditional Chinese Medicine Composition Containing Chinese Herbaceous Peony and Fresh Ginger. Yi Yueneng, Liu Ying, Fu Meng, Shi Shiyuan, Xue Qin, ..

Jiangsu Hi Stone Pharmaceutical Co Ltd Seeks Patent for Headspace Gas Chromatography Method for Detecting Residual Quantity of Ethanol in Gastrodin

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Jiangsu Hi Stone Pharmaceutical Co Ltd has sought patent for Headspace Gas Chromatography Method for Detecting Residual Quantity of Ethanol in Gastrodin. This invention was developed by Wei Genghu, Sun Zhengyu and Yang Yu. The patent application number is CN202511857069 20251210. The patent publication num..

State Intellectual Property Office of China Releases Hunan Yineng Biological Medicine Co Ltd Patent Application for Quality Control Method and Application of Traditional Chinese Me..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has released Hunan Yineng Biological Medicine Co Ltd patent application for Quality Control Method and Application of Traditional Chinese Medicine Compound Containing Bighead Atractylodes Rhizome, Chinese Yam and Ginseng. This invention was developed by Yi Yueneng, ..

Jiangsu Pacific Meinuoke Biopharmaceutical Co Ltd Seeks Patent for Peptide Diagram Detection Method of Anti-human Cd147 Antibody

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Jiangsu Pacific Meinuoke Biopharmaceutical Co Ltd has sought patent for Peptide Diagram Detection Method of Anti-human Cd147 Antibody. This invention was developed by Yang Tianyi, Tang Hao and Chen Xiaochun. The patent application number is CN202511700321 20251119. The patent publication number is CN121595..

State Intellectual Property Office of China Receives Hubei Lingsheng Pharmaceuticals Co Ltd Patent Application for Method for Determining Residual Tetramethylguanidine in Cefcapene..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has received Hubei Lingsheng Pharmaceuticals Co Ltd patent application for Method for Determining Residual Tetramethylguanidine in Cefcapene Pivoxil Hydrochloride by High Performance Liquid Chromatography. Xu Jianjun, Zhang Kaiwen, Li Hongwei and Xia Binghao develop..

State Intellectual Property Office of China Releases Suzhou Enhua Biomedical Tech Co Ltd and Jiangsu Nhwa Pharmaceutical Patent Application for Method for Detecting Related Substan..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has released Suzhou Enhua Biomedical Tech Co Ltd and Jiangsu Nhwa Pharmaceutical patent application for Method for Detecting Related Substances in Paliperidone. This invention was developed by Chu Kaihui, Wang Mingli, Lu Xiuli, Yang Yan, Xu Chunlai, Dong Dawen and X..

State Intellectual Property Office of China Publishes Zhongshan Wanhan Pharmacy Co Ltd and Zhongshan Wanyuan New Drug Res And Development Co Ltd Patent Application for Method for D..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has published Zhongshan Wanhan Pharmacy Co Ltd and Zhongshan Wanyuan New Drug Res And Development Co Ltd patent application for Method for Detecting Azido Derivative Impurities in Oseltamivir Phosphate Bulk Drug. The invention was developed by Xiang Fei, Du Zhibo, W..

State Intellectual Property Office of China Releases Beijing Sunho Pharmaceutical Co Ltd Patent Application for Method for Detecting Content of Rifamycin Sodium Injection by High P..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has released Beijing Sunho Pharmaceutical Co Ltd patent application for Method for Detecting Content of Rifamycin Sodium Injection by High Performance Liquid Chromatography. This invention was developed by Dai Xinyao, Li Shan, Xiu Yong and Zhao Lei. The patent ap..

Shanghai Aobo Bio Pharmaceutical Co Ltd Applies for Patent on Method for Analyzing Polypeptide or Protein in Sample to be Detected

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Shanghai Aobo Bio Pharmaceutical Co Ltd has applied Chinese patent for Method for Analyzing Polypeptide or Protein in Sample to be Detected. Zhu Guangshan, Hu Suzhao, Zhang Lijuan, An Jianguo and Gu Hong developed it. The patent application number is CN202411118824 20240815. The patent publication number i..

Huazhong Pharmaceutical Co Ltd Seeks Patent for Method for Determining Ethambutol Hydrochloride Content Based on Surface Enhanced Raman Spectroscopy

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Huazhong Pharmaceutical Co Ltd has sought patent for Method for Determining Ethambutol Hydrochloride Content Based on Surface Enhanced Raman Spectroscopy. This invention was developed by Zheng Binxing, Feng Fenyan, Wang Meinan and Tang Wei. The patent application number is CN202511500069 20251020. The pate..

State Intellectual Property Office of China Releases Tianjin Polytechnic University and Shaoxing Keqiao Research Inst Tianjin University Of Technology Patent Application for Choles..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has released Tianjin Polytechnic University and Shaoxing Keqiao Research Inst Tianjin University Of Technology patent application for Cholesterol Sensor Based on Mmi-mzi Structure and Detection Method. This invention was developed by Li Hongqiang, Yang Yueting, Li X..

State Intellectual Property Office of China Publishes Yueyang Vocational Technical College Patent Application for Rapid Detector for Effective Components of Medicinal Materials

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has published Yueyang Vocational Technical College patent application for Rapid Detector for Effective Components of Medicinal Materials. The invention was developed by Tan Qiulian, Teng Shujing, Zhu Mengmeng and Sun Jing. The patent application number is CN20251..

State Intellectual Property Office of China Publishes Ningbo Yuanxin Electronic Co Ltd Patent Application for Membrane Type Pressure Sensor for Monitoring Cun-guan-chi Pulse in Tra..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has published Ningbo Yuanxin Electronic Co Ltd patent application for Membrane Type Pressure Sensor for Monitoring Cun-guan-chi Pulse in Traditional Chinese Medicine Pulse Feeling and Preparation Method of Membrane Type Pressure Sensor. The invention was developed b..

State Intellectual Property Office of China Publishes Shanghai Jiao Tong University and Southeast University Patent Application for Method for Monitoring Temperature in Cold and Ho..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has published Shanghai Jiao Tong University and Southeast University patent application for Method for Monitoring Temperature in Cold and Hot Cycling Process. The invention was developed by Di Siyi, Tang Zijue, Wang Hongze, Wu Yi, Choi Jung Hyun and Hu Fan. The p..

9163 0384 Quebec Inc Submits Taiwan Patent Application for Assessment of Chylomicronemia Using Vitamin E

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- 9163 0384 Quebec Inc has submitted a patent application for Assessment of Chylomicronemia Using Vitamin E. This invention was developed by Gaudet Daniel and Larouche Miriam. The patent application number is TW20240137268 20240930. The patent publication number is TW202530700 (A). International Patent Classi..

Taiwan Patent Office Releases National Health Res Inst and National Taiwan Univ Hospital Hsin Chu Branch Patent Application for Method and Kit for Predicting Drug Efficacy of Lung ..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has released National Health Res Inst and National Taiwan Univ Hospital Hsin Chu Branch patent application for Method and Kit for Predicting Drug Efficacy of Lung Cancer Treatment and Method for Treating Lung Cancer. This invention was developed by Lee Chia-huei and Huang Hsien-neng. Th..

Taiwan Patent Office Receives Bell Polyester Products Inc and Daiwa Can Patent Application for Polyester Film, Laminate, Package, Food and Drink Package, Cosmetic Package, Pharmace..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has received Bell Polyester Products Inc and Daiwa Can patent application for Polyester Film, Laminate, Package, Food and Drink Package, Cosmetic Package, Pharmaceutical and Quasi-drug Package, and Product. Kubo Kenta, Mise Yoshiyuki and Degura Tsuyoshi developed the invention. The pate..

Ya Therapeutics Inc Submits Taiwan Patent Application for Preparation and Use of Pyrimidothiopyranone KRAS Mutant Protein Inhibitor Exhibiting Potent Activity in Inhibiting Tumor G..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Ya Therapeutics Inc has submitted a patent application for Preparation and Use of Pyrimidothiopyranone KRAS Mutant Protein Inhibitor Exhibiting Potent Activity in Inhibiting Tumor Growth and Good Safety. This invention was developed by Liang Yong-hong. The patent application number is TW20240148232 20241211..

Hunan Yineng Biological Medicine Co Ltd Submits Chinese Patent Application for Thin-layer Identification Method for Traditional Chinese Medicine Compound Preparation Containing Rhi..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Hunan Yineng Biological Medicine Co Ltd has submitted a patent application for Thin-layer Identification Method for Traditional Chinese Medicine Compound Preparation Containing Rhizoma Atractylodis Macrocephalae and Fresh Ginger and Application of Thin-layer Identification Method. This invention was developed..

State Intellectual Property Office of China Publishes Hunan Yineng Biological Medicine Co Ltd Patent Application for Thin-layer Identification Method for Traditional Chinese Medici..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has published Hunan Yineng Biological Medicine Co Ltd patent application for Thin-layer Identification Method for Traditional Chinese Medicine Compound Preparation Containing Angelica Sinensis and Pericarpium Citri Reticulatae and Application of Thin-layer Identific..

Jiangxi Kerui Pharmaceutical Co Ltd Seeks Patent for Method for Detecting 2, 5-dichloro-4, 6-dimethyl Nicotinonitrile Related Substances of Starting Material of Olpicopone

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Jiangxi Kerui Pharmaceutical Co Ltd has sought patent for Method for Detecting 2, 5-dichloro-4, 6-dimethyl Nicotinonitrile Related Substances of Starting Material of Olpicopone. This invention was developed by Zhang Junping, Cai Lipeng, Xie Xinhong, Luo Hengzhen and Fu Min. The patent application number is..

Jiangsu Jiming Pharmaceutical Co Ltd Submits Chinese Patent Application for Method for Detecting N-nitrosobisoprolol by Liquid Chromatograph-mass Spectrometer

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Jiangsu Jiming Pharmaceutical Co Ltd has submitted a patent application for Method for Detecting N-nitrosobisoprolol by Liquid Chromatograph-mass Spectrometer. This invention was developed by Wu Xianzhi, Tang Rongping, Li Jundong, Liu Hui and Shen Qiuping. The patent application number is CN202610129887 20..

State Intellectual Property Office of China Releases Hunan Yineng Biological Medicine Co Ltd Patent Application for Quality Control Method and Application of Traditional Chinese Me..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has released Hunan Yineng Biological Medicine Co Ltd patent application for Quality Control Method and Application of Traditional Chinese Medicine Compound Containing Gardenia Kernel. This invention was developed by Yi Yueneng, Zhu Yawen, Tang Chaohui, Xie Zhicheng,..

Zhejiang Hisun Pharm Co Ltd and Shanghai Aryl Pharmtech Co Ltd File Taiwan Patent Application for Aromatic Amide Derivative, and Preparation Method Therefor and Use Thereof

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Zhejiang Hisun Pharm Co Ltd and Shanghai Aryl Pharmtech Co Ltd have filed a patent application for Aromatic Amide Derivative, and Preparation Method Therefor and Use Thereof. This invention was developed by Qiu Zong-xing, Cao Hai, Peng Ji-lei, Wang Ze-feng, Ye Cheng, Shi Ya-qiong, Zhang Heng, Yu Ming-feng and ..

Terremoto Biosciences Inc Submits Patent Application for Cysteine Covalent Modifiers of Akt1 and Uses Thereof

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Terremoto Biosciences Inc has submitted a patent application for Cysteine Covalent Modifiers of Akt1 and Uses Thereof. Chu Hang, Reisberg Solomon H, Zajdlik Adam, Yang Kin S, Carelli Jordan D and Thompson Peter A developed the invention. The patent application number is TW20240138829 20241011. The patent pu..

Neuboron Medtech Res Institute Ltd Submits Patent Application for a Multi-boron Complex and its Preparation and Application

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Neuboron Medtech Res Institute Ltd has submitted a patent application for a Multi-boron Complex and its Preparation and Application. Yuan Zhen-wei, Liu Ji, Lin Jing-jing and Wang Yu-xin developed the invention. The patent application number is TW20240150065 20241220. The patent publication number is TW20253..

Taiwan Patent Office Receives Regeneron Pharmaceuticals Patent Application for Lyophilization Using Controlled Nucleation

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has received Regeneron Pharmaceuticals patent application for Lyophilization Using Controlled Nucleation. Tang Xiaolin, Chen Yao, Kleppe Mary, Ingram Sarah and Sharma Saurav developed the invention. The patent application number is TW20240136959 20240927. The patent publication number is ..

Denali Therapeutics Seeks Patent for Modified Glucocerebrosidase Polypeptides and Methods of Use Thereof

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Denali Therapeutics has sought patent for Modified Glucocerebrosidase Polypeptides and Methods of Use Thereof. This invention was developed by Kariolis Mihalis S and Qerqez Ahlam Nabil. The patent application number is TW20240147466 20241206. The patent publication number is TW202532096 (A). International Pat..

Shanghai Argo Biopharmaceutical Files Taiwan Patent Application for Compositions and Methods for Inhibiting Expression of Huntingtin (htt)

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Shanghai Argo Biopharmaceutical has filed a patent application for Compositions and Methods for Inhibiting Expression of Huntingtin (htt). This invention was developed by Shu Dong-xu, Shao Pengcheng Patrick, Xia Shi-wei and Zhang Yong-quan. The patent application number is TW20250104550 20250207. The patent p..

Taiwan Patent Office Publishes Gilead Sciences Patent Application for Pharmaceutical Formulations and Uses Thereof

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has published Gilead Sciences patent application for Pharmaceutical Formulations and Uses Thereof. The invention was developed by Barrett Kimberly T and Bunyan Elaine. The patent application number is TW20250113859 20231026. The patent publication number is TW202532085 (A). Internationa..

Gilead Sciences Applies for Patent on Remdesivir Treatment Methods

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Gilead Sciences has applied Taiwan patent for Remdesivir Treatment Methods. Cihlar Tomas developed it. The patent application number is TW20240138493 20210528. The patent publication number is TW202532084 (A). International Patent Classification codes are A61K31/706 and A61P31/14. Cooperative Patent Classif..

Anxo Pharmaceutical Submits Taiwan Patent Application for Pharmaceutical Composition and Use Thereof

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Anxo Pharmaceutical has submitted a patent application for Pharmaceutical Composition and Use Thereof. This invention was developed by Su Chia-yu, Tseng Hsiu-chuan, Jhan Hua-jing, Chen Tse-hsien and Jian Chi-heng. The patent application number is TW20250103719 20250203. The patent publication number is TW2025..

Taiwan Patent Office Receives BeiGene Switzerland Patent Application for Treating B-cell Proliferative Disorder with Chimeric Degradation Activating Compound

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has received BeiGene Switzerland patent application for Treating B-cell Proliferative Disorder with Chimeric Degradation Activating Compound. Paik Jason, Tariq Bilal and Vosganian Gregory developed the invention. The patent application number is TW20250104655 20250207. The patent public..

Duality Biologics Suzhou Files Taiwan Patent Application for Ecteinascidin Compound and Use Thereof

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Duality Biologics Suzhou has filed a patent application for Ecteinascidin Compound and Use Thereof. This invention was developed by Yi Lei, Zhang Yu, Lin Sheng-chao, Hua Hai-qing and Zhu Zhong-yuan. The patent application number is TW20250104636 20250207. The patent publication number is TW202532075 (A). In..

Chia Tai Tianqing Pharmaceutical Group Submits Taiwan Patent Application for Compound Containing Pyrazole Ring and Bicyclic Heteroaryl Group, Pharmaceutical Composition Thereof and..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Chia Tai Tianqing Pharmaceutical Group has submitted a patent application for Compound Containing Pyrazole Ring and Bicyclic Heteroaryl Group, Pharmaceutical Composition Thereof and Use Thereof. This invention was developed by Liu Fei, Feng Tao-tao, Meng Qing-yi, Xu Hong-jiang, Shi Wei and Bi Cheng. The paten..

Chia Tai Tianqing Pharmaceutical Group Submits Taiwan Patent Application for Compound Containing Heterocyclic Dihydrophthalazine

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Chia Tai Tianqing Pharmaceutical Group has submitted a patent application for Compound Containing Heterocyclic Dihydrophthalazine. This invention was developed by Liu Fei, Xu Hong-jiang, Gu Jia-jia, Shi Wei and Gao Peng. The patent application number is TW20240145911 20241127. The patent publication number is..

EA Pharma Seeks Patent for Pharmaceutical Composition

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- EA Pharma has sought patent for Pharmaceutical Composition. This invention was developed by Sugiura Daisuke, Arisaka Harumi, Nakahara Wataru and Hirano Satoshi. The patent application number is TW20240146356 20241129. The patent publication number is TW202532060 (A). International Patent Classification codes ..

Shanghai Regenelead Therapies Applies for Patent on a Composition and Compound for Delivering Therapeutic Agents

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Shanghai Regenelead Therapies has applied Taiwan patent for a Composition and Compound for Delivering Therapeutic Agents. Liu Chong-yi, Jiang Jun, Huang Jian, Zhu Ling-jian, Kuang Jing-wen, Zou Yang, Ning Wei and Liao Cheng developed it. The patent application number is TW20240148770 20241213. The patent publ..

Hoffmann La Roche Applies for Patent on Monitoring Populations of Cells Producing Biomolecules

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Hoffmann La Roche has applied Taiwan patent for Monitoring Populations of Cells Producing Biomolecules. Auslaender Simon, Bauer Niels and Popp Oliver developed it. The patent application number is TW20240147188 20241205. The patent publication number is TW202530411 (A). International Patent Classification cod..

Taiwan Patent Office Releases Ionis Pharmaceuticals Patent Application for Compounds and Methods for Inhibiting Lpa

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has released Ionis Pharmaceuticals patent application for Compounds and Methods for Inhibiting Lpa. This invention was developed by Kubli Dieter, Mullick Adam, Prakash Thazha P and Swayze Eric E. The patent application number is TW20240135743 20240920. The patent publication number is TW2..

Osprey Biopharmaceuticals Files Taiwan Patent Application for Polypeptides Having Human IgG Cleavage Activity

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Osprey Biopharmaceuticals has filed a patent application for Polypeptides Having Human IgG Cleavage Activity. This invention was developed by Deporter Sandra M. The patent application number is TW20240136463 20240925. The patent publication number is TW202530404 (A). International Patent Classification code..

Hoffmann La Roche Files Taiwan Patent Application for Cell Culturing Device

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Hoffmann La Roche has filed a patent application for Cell Culturing Device. This invention was developed by Pereiro Iago, Garcia Cordero Jose Luis, Ceylan Eylul, Hauser Janosch, Aubert Julien and Kronabitter Hannah Theresa. The patent application number is TW20240149599 20241219. The patent publication numb..

Taiwan Patent Office Publishes National Health Research Institute Patent Application for Inhibitors of Epidermal Growth Factor Receptor

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has published National Health Research Institute patent application for Inhibitors of Epidermal Growth Factor Receptor. The invention was developed by Hsieh Hsing-pang, Li Mu-chun and Lin Shu-yu. The patent application number is TW20240104421 20240205. The patent publication number is T..

Hoffmann La Roche Seeks Patent for Solid Forms of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indol-2-y..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Hoffmann La Roche has sought patent for Solid Forms of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and Processes for Preparing Fused Tricyclic Compounds Comprising a Substituted Phenyl or Pyridinyl ..

Amgen Files Taiwan Patent Application for Improved Synthesis of KRAS G12C Inhibitor Compound

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Amgen has filed a patent application for Improved Synthesis of KRAS G12C Inhibitor Compound. This invention was developed by Parsons Andrew T and Beaver Matthew G. The patent application number is TW20250112959 20201113. The patent publication number is TW202532412 (A). International Patent Classification cod..

Taiwan Patent Office Releases Chong Kun Dang Pharmaceutical Corp Patent Application for Glp-1 Receptor Agonist, and Uses Thereof

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has released Chong Kun Dang Pharmaceutical Corp patent application for Glp-1 Receptor Agonist, and Uses Thereof. This invention was developed by Min Jae-ki, Park Ji-hye, Kim Yi-hyun, Goo Kyo-young and Yoon Hong-ju. The patent application number is TW20250104750 20250208. The patent public..

Affiliated Hospital of Nantong University Applies for Patent on Application of Lactic Acid Modified Histone H3 in Preparation of Medicine and/or Diagnostic Kit for Preventing and/o..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Affiliated Hospital of Nantong University has applied Chinese patent for Application of Lactic Acid Modified Histone H3 in Preparation of Medicine and/or Diagnostic Kit for Preventing and/or Treating Pancreatic Ductal Adenocarcinoma. Xiao Mingbing, Zhao Junpeng, Xu Xuebing, Qian Kunyan, Xu Weisong, Jiang Wei,..

Shenyang Pharmaceutical University Submits Chinese Patent Application for Biological Membrane Dynamic Intervention Test Device Based on Micro-fluidic-photo-thermal Synergy

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Shenyang Pharmaceutical University has submitted a patent application for Biological Membrane Dynamic Intervention Test Device Based on Micro-fluidic-photo-thermal Synergy. This invention was developed by Deng Haojun and Cui Yong. The patent application number is CN202511824371 20251205. The patent publicati..

State Intellectual Property Office of China Publishes Guizhou University of Traditional Chinese Medicine Patent Application for Research Method for Action Mechanism of Herba Ephedr..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has published Guizhou University of Traditional Chinese Medicine patent application for Research Method for Action Mechanism of Herba Ephedrae in Treatment of Chronic Obstructive Pulmonary Disease in Acute Exacerbation Period. The invention was developed by Li Zhe, ..

University Liaoning Traditional Chinese Medicine Submits Chinese Patent Application for Quality Control Method for Traditional Chinese Medicine Motherwort in Different Harvesting P..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- University Liaoning Traditional Chinese Medicine has submitted a patent application for Quality Control Method for Traditional Chinese Medicine Motherwort in Different Harvesting Periods. This invention was developed by Bao Yongrui, Wang Shuai, Yang Xinxin, Meng Xiansheng, Li Tianjiao and Zheng Tiantian. The..

Shandong Luye Pharmaceutical Submits Patent Application for Method for Detecting Various Amine and Nitrosamine Impurities in Quetiapine Fumarate Raw Material Medicine or Preparatio..

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Shandong Luye Pharmaceutical has submitted a patent application for Method for Detecting Various Amine and Nitrosamine Impurities in Quetiapine Fumarate Raw Material Medicine or Preparation. Chu Xuemei, Sun Zhen, Liu Xiaoyan, Chen Juan, Xue Ying, Zhang Xuemei, Ding Jiaxin, Fu Fenghua, Tian Jingwei and Wang Si..

Tianjin University Applies for Patent on Dredging Equipment for River Regulation Engineering

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Tianjin University has applied Chinese patent for Dredging Equipment for River Regulation Engineering. Liu Xin, Zhuang Xiaorui, Hua Shuyu, Shang Ming and Li Hongwei developed it. The patent application number is CN202511997379 20251227. The patent publication number is CN121593517 (A). International Patent C..

Odyssey Therapeutics Applies for Patent on Anti-CDH17 Antigen-binding Proteins and Uses Thereof

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Odyssey Therapeutics has applied Taiwan patent for Anti-CDH17 Antigen-binding Proteins and Uses Thereof. Franchi Luigi, Opipari Anthony W, Pinheiro Elaine Maria, Abraham Robert Thomas, Preiss Laura, Huber Ferdinand, Konig Paul-albert and Dake Tamara developed it. The patent application number is TW202401385..

Taiwan Patent Office Receives Oyster Point Pharma Patent Application for Insulin-like Growth Factor-1 Receptor (igf1r) Antibodies and Related Methods of Treatment

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has received Oyster Point Pharma patent application for Insulin-like Growth Factor-1 Receptor (igf1r) Antibodies and Related Methods of Treatment. Carlson Eric C developed the invention. The patent application number is TW20240136243 20240924. The patent publication number is TW202530261 ..

Zealand Pharma Submits Taiwan Patent Application for Method

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Zealand Pharma has submitted a patent application for Method. This invention was developed by Vestergaard Bill. The patent application number is TW20240147045 20241204. The patent publication number is TW202530247 (A). International Patent Classification codes are A61K38/16, A61P3/00, A61P3/04, A61P9/00 and C..

Regeneron Pharmaceuticals Submits Taiwan Patent Application for Methods and Systems for Developing Chromatography Protocols

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Regeneron Pharmaceuticals has submitted a patent application for Methods and Systems for Developing Chromatography Protocols. This invention was developed by Gupta Nimish, Cowan Christopher and Mattila John. The patent application number is TW20240135290 20240918. The patent publication number is TW202530239 ..

University of Hong Kong Submits Patent Application for Luminescent Tetradentate Ligand Gold(III) Compounds for Organic Light-emitting Devices and Their Preparation

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- University of Hong Kong has submitted a patent application for Luminescent Tetradentate Ligand Gold(III) Compounds for Organic Light-emitting Devices and Their Preparation. Yam Vivian Wing-wah, Kwong Ka Wai, Chan Mei-yee and Wong Yiu-wing developed the invention. The patent application number is TW202401334..

Taiwan Patent Office Receives Eli Lilly and Company Patent Application for KRAS Inhibitors

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has received Eli Lilly and Company patent application for KRAS Inhibitors. Barberis Mario, Carballares Martin Santiago, Florez Victoriano Molero, Rojo Garcia Isabel, Guo Deqi, Johnston Richard Duane and Zhao Gai-ying developed the invention. The patent application number is TW20240136914 ..

Shanghai Jemincare Pharmaceuticals Submits Taiwan Patent Application for Preparation Methods, Applications and Uses of Nitrogen Heterocyclic Amine Compounds as Ubiquitin-specific P..

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Shanghai Jemincare Pharmaceuticals has submitted a patent application for Preparation Methods, Applications and Uses of Nitrogen Heterocyclic Amine Compounds as Ubiquitin-specific Protease 1 Inhibitor. This invention was developed by Bie Ping-yan, Zhang Fei and Peng Jian-biao. The patent application number is..

Taiwan Patent Office Receives Hoffmann La Roche Patent Application for Process for Manufacturing Baloxavir Marboxil

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has received Hoffmann La Roche patent application for Process for Manufacturing Baloxavir Marboxil. Barbato Keith Steven, Born Stephen Christopher and Chakrabarty Rajshree developed the invention. The patent application number is TW20240137757 20241004. The patent publication number is TW..

Halda Therapeutics OpCo Submits Taiwan Patent Application for Heterobifunctional Compounds and Methods of Treating Disease

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Halda Therapeutics OpCo has submitted a patent application for Heterobifunctional Compounds and Methods of Treating Disease. This invention was developed by Eastman Kyle J, Kayser-bricker Katherine J, Mousseau James John, Martin Michael Barrington, Perry Matthew Alexander, Puleo David E, Raina Kanak Shail, Zaw..

Sitryx Therapeutics Submits Taiwan Patent Application for Novel Compounds

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Sitryx Therapeutics has submitted a patent application for Novel Compounds. This invention was developed by Mazzacani Alessandro, Greenidge Paulette, Teobald Barry, Fyfe Matthew, Barba Oscar, Ricci Paolo, Garcia Carlos Turrado, Piton Nelly and Matherson Christopher. The patent application number is TW20240138..

Synnovation Therapeutics Seeks Patent for Tricyclic Compounds as Pi3k[alpha] Inhibitors

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Synnovation Therapeutics has sought patent for Tricyclic Compounds as Pi3k[alpha] Inhibitors. This invention was developed by Qi Chao, Zhou Fei, Li Yu, Zheng He-wen, Wu Liangxing and Yao Wenqing. The patent application number is TW20240139267 20241016. The patent publication number is TW202530214 (A). Interna..

Taiwan Patent Office Receives Blueprint Medicines Patent Application for Salt and Solid Forms of an EGFR Inhibitor

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has received Blueprint Medicines patent application for Salt and Solid Forms of an EGFR Inhibitor. De Paolis Omar, Heinrich Brian, Kauffman Goss Stryker, Kinkema Caitlin N, Li Hui, Stutz Alfred and Ohmer Harald developed the invention. The patent application number is TW20240138573 2024..

Incyte Corp Submits Taiwan Patent Application for Crystalline Forms of a KRAS Inhibitor

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Incyte Corp has submitted a patent application for Crystalline Forms of a KRAS Inhibitor. This invention was developed by Hu Jiemin, Jia Zhongjiang, Sheth Trupti, Su Nai-jing and Zhang Huaping. The patent application number is TW20240138562 20241009. The patent publication number is TW202530210 (A). Internati..

Design Therapeutics Seeks Patent for Methods and Compounds for Modulating Huntington's Disease

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Design Therapeutics has sought patent for Methods and Compounds for Modulating Huntington's Disease. This invention was developed by Nourie Hannah, Sinha Santosh, Waybright Jarod, Yang Fei, Zhang Chengzhi, Convertino Marino and Yeh Chien-hung. The patent application number is TW20240137718 20241003. The paten..

Janssen Pharmaceutica Submits Taiwan Patent Application for SMARCA2 Inhibitors Useful for the Treatment of SMARCA4 Deficient Cancers

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Janssen Pharmaceutica has submitted a patent application for SMARCA2 Inhibitors Useful for the Treatment of SMARCA4 Deficient Cancers. This invention was developed by Stansfield Ian, De Boeck Benoit Christian Albert Ghislain, Salacz Laura, Basile Eugenio, Obradors Llobet Carla, Jones Alexander Xenophon, Krawcz..

Shanghai Jiao Tong University Submits Chinese Patent Application for Optical Communication System Sample Dynamic Modeling Method and System

Pharmaceutical

| Sat 13 Jun 2026

Beijing, June 13 -- Shanghai Jiao Tong University has submitted a patent application for Optical Communication System Sample Dynamic Modeling Method and System. This invention was developed by Qiu Qizhi, Zhuge Qunbi, Zhang Yihao and Yu Xiaoshu. The patent application number is CN202511742884 20251125. The patent publication num..

State Intellectual Property Office of China Releases Jilin University Patent Application for Traditional Chinese Medicine Granule Quality Control Method Based on Characteristic Fin..

Pharmaceutical

| Fri 12 Jun 2026

Beijing, June 13 -- State Intellectual Property Office of China has released Jilin University patent application for Traditional Chinese Medicine Granule Quality Control Method Based on Characteristic Fingerprint Spectrum. This invention was developed by Zhang Ming, Guan Renchu and Chen Yan. The patent application number is CN2..

Taiwan Patent Office Publishes Vaxcyte Inc and University of North Carolina at Chapel Hill Patent Application for Chlamydia Vaccine Compositions

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has published Vaxcyte Inc and University of North Carolina at Chapel Hill patent application for Chlamydia Vaccine Compositions. The invention was developed by Rozelle James, Fairman Jeff, Poston Taylor and Darville Lee Antoinette. The patent application number is TW20240137713 20241003..

Taiwan Patent Office Receives Rednvia Co Ltd Patent Application for Tnap Inhibitory Compound and Use Thereof

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has received Rednvia Co Ltd patent application for Tnap Inhibitory Compound and Use Thereof. Ku Il-whea, Jo Yong-hwa, Kwon Hye-shin and Kwon Min-jeong developed the invention. The patent application number is TW20240142508 20241106. The patent publication number is TW202532058 (A). Inte..

Taiwan Patent Office Receives Asfreya Inc Patent Application for Medicinal Composition and Treatment Method Using Same

Pharmaceutical

| Sat 13 Jun 2026

Taipei, June 13 -- Taiwan Patent Office has received Asfreya Inc patent application for Medicinal Composition and Treatment Method Using Same. Ochiya Takahiro developed the invention. The patent application number is TW20250102571 20250121. The patent publication number is TW202532093 (A). International Patent Classification ..

1 to 100 of 1619 Items Next >>

Home
|
About Us
|
Privacy Policy
|
Support
|
Products
|
Careers
|
Contact Us

© Copyright 2015. All Right Reserved.

Email selected articles